Aminophylline-associated irritable behaviour in preterm neonates.

Area of Science:

• Neonatal Medicine
• Developmental Pediatrics
• Pharmacology

Background:

• Preterm infants often experience behavioral and autonomic challenges.
• Aminophylline is used to manage conditions like apnea in neonates.
• Understanding aminophylline's impact on preterm infant development is crucial.

Purpose of the Study:

• To investigate the effects of aminophylline on behavior and autonomic function in preterm infants.
• To assess changes in general movements (GM) optimality and autonomic parameters.
• To compare outcomes at different gestational age periods.

Main Methods:

• Study included preterm infants receiving aminophylline (Am+) and a control group (Am-).
• Behavior assessed using general movement optimality (onset-offset, tremulous movements).
• Autonomic function evaluated via heart rate and heart rate variability analysis.

Main Results:

• The aminophylline group showed significantly lower optimality of tremulous movements at 32-33 weeks gestation.
• No significant differences in autonomic parameters were observed between the groups.
• No correlation found between GM optimality scores and serum theophylline concentration.

Conclusions:

• Aminophylline administration is associated with transient irritable behavior in preterm infants.
• No significant impact on autonomic function was detected during the preterm period.
• Further research may explore long-term behavioral effects.